Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort)

Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort)

Early COVID-19 treatments can prevent progression to severe disease. However, real-life data are still limited, and studies are warranted to monitor the efficacy and tolerability of these drugs. We retrospectively enrolled outpatients receiving early treatment for COVID-19 in 11 infectious diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Tommaso Manciulli, Michele Spinicci, Barbara Rossetti, Roberta Maria Antonello, Filippo Lagi, Anna Barbiero, Flavia Chechi, Giuseppe Formica, Emanuela Francalanci, Mirco Alesi, Samuele Gaggioli, Giulia Modi, Sara Modica, Riccardo Paggi, Cecilia Costa, Alessandra Morea, Lorenzo Paglicci, Ilaria Rancan, Francesco Amadori, Agnese Tamborrino, Marta Tilli, Giulia Bandini, Alberto Moggi Pignone, Beatrice Valoriani, Francesca Montagnani, Mario Tumbarello, Pierluigi Blanc, Massimo Di Pietro, Luisa Galli, Donatella Aquilini, Antonella Vincenti, Spartaco Sani, Cesira Nencioni, Sauro Luchi, Danilo Tacconi, Lorenzo Zammarchi, Alessandro Bartoloni
Formato: Artículo
Lenguaje:English
Publicado: MDPI AG 2023-02-01
Colección:Viruses
Materias:
SARS-CoV-2
COVID-19
sotrovimab
nirmatrelvir/ritonavir
molnupiravir
remdesivir
Acceso en línea:https://www.mdpi.com/1999-4915/15/2/438

Internet

https://www.mdpi.com/1999-4915/15/2/438

Ejemplares similares